# Pemetrexed and Cisplatin in Advanced Urothelial Carcinoma

> **NCT01490437** · PHASE2 · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 42 (actual)

## Conditions studied

- Urothelial Carcinoma

## Interventions

- **DRUG:** Pemetrexed
- **DRUG:** Cisplatin
- **DRUG:** Dexamethasone
- **DRUG:** Vitamins

## Key facts

- **NCT ID:** NCT01490437
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2014-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01490437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01490437, "Pemetrexed and Cisplatin in Advanced Urothelial Carcinoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01490437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*